CO poisoning Flashcards
1
Q
Oxygen
Common indications
A
- To increase tissue oxygen delivery in states of hypoxaemia
- To accelerate reabsorption of pleural gas in pneumothorax
- To reduce the half-life of carboxyhaemoglobin in CO poisoning
2
Q
Oxygen
MOA
A
- An abnormally low Partial pressure of oxygen (PO2) in arterial blood (PaO2), termed hypoxaemia, may be a consequence of a wide range of disease processes
- Its effect is to reduce the delivery of oxygen to tissues (hypoxia), forcing them to use anaerobic metabolism for energy generation
- Supplemental oxygen therapy increases the PO2 in alveolar gas, driving more rapid diffusion of oxygen into the blood
- The resultant increase in PaO2, increase delivery of O2 to tissues, which in effect ‘buys time; while the underlying disease is corrected
- In Pneumothorax, supplemental oxygen therapy has an additional benefit of reducing the fraction of nitrogen in alveolar gas
- This accelerates the diffusion of nitrogen out of the body
- Since pleural air is composed mostly of nitrogen, this increases its rate of reabsorption
- In CO poisoning, oxygen competes with CO to bind with haemoglobin and thereby shortens the half-life of carboxyhaemoglobin, returning haemoglobin to a form that can again transport oxygen to tissues
3
Q
Oxygen
Important adverse effects
A
- The most common adverse effects are related to the delivery device (e.g. discomfort of the mask) or its lack of water vapour leading to dry mouth/throat
- The latter can be improved by using a humidification system
- Except in pneumothorax and CO poisoning, there is little to be gained from having abnormally high PaO2, there is some evidence that it may be harmful
- However, this concern should not lead you to withhold oxygen in critical illness or states of severe hypoxaemia in which oxygen is lifesaving
4
Q
Oxygen
Prescription
A
- Oxygen therapy should always be guided by a written prescription except in emergencies when it may initially be administered without a prescription
- The oxygen prescription is usually found on a dedicated section of the drug chart or a separate chart
- Its key feature is the target oxygen saturation range, as measured by pulse oximetry (SpO2)
- The target SpO2 should be 94-98% in most patients and 88-92% in those with chronic type 2 respiratory failure
- For the initial delivery device, in general, prescribe a reservoir mask in critical illness and patients with SpO2 <85%; a venturi (28%) for patients in chronic type 2 respiratory failure, and nasal cannulae for everyone else
5
Q
Oxygen
Monitoring
A
- SpO2 monitoring is essential in all patients receiving oxygen for acute illness
- The device and or flow rate should be adjusted as necessary to keep the SpO2 within the target range
- In addition, arterial blood gas measurement is essential in patients with a critical illness, those with chronic type 2 respiratory failure or at risk of hypercapnia and those with hypoxaemia that is unexpected, progressive or disproportionate to their illness
6
Q
A